ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

AAM. 2025; 14(2): 98-105


Phytochemical Screening and Evaluation of Haemolytic Potential of Medicinal Plant Withania coagulans Fruit

Mohan Kumar H. M.,Swechchha K. M..



Abstract
Download PDF Post

Scientific validation of any medicinal plant for bioactive molecules and their toxicity study is important during drug development. In the present study, phytochemical analysis of Withania coagulans plant fruit methanolic extract reported the presence of major phytochemical groups including alkaloid, carbohydrate, tannin, terpenoid, glycoside, steroid and flavanoid. The haemolytic activity of W. coagulans plant fruit methanolic extract was performed by spectroscopic method at six different concentrations (6.25, 12.5, 25, 50, 100 and 200 µg/ml). The solvent fractions exhibited very low haemolytic activity towards human erythrocytes. W. coagulans plant fruit extract has showed 22.54% of haemolysis at its highest test concentration (200 µg/ml). Hence, as the haemolysis percentage is very less, W. coagulans plant fruit crude extract could be regarded as safe for human erythrocytes.

Key words: Phytochemical; Haemolytic Potential; Withania coagulans.







Bibliomed Article Statistics

19
16
10
7
13
9
19
19
28
12
8
3
R
E
A
D
S

22

25

9

11

10

15

19

25

20

16

14


D
O
W
N
L
O
A
D
S
070809101112010203040506
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.